MetaCap

Capstone Quarterly Income Statement

NASDAQ: CAPSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.44-0.145 (-9.15%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Capstone revenue and earnings

In the quarter ended Sep 30, 2026, Capstone generated $20.0 million in revenue, up 46.2% from the same quarter a year earlier. Capstone reported a net loss of $632,000, compared with a loss of $2.0 million a year earlier. Gross margin was 28.7% (up from 23.8%) and operating margin 2.0%.

Summary generated from market data by MetaCap's automated system. Methodology

Capstone income statement (quarterly)

Capstone quarterly income statement
Quarter (USD)Q3 20262026-09-30Q2 20262026-06-30Q1 20262026-03-31Q4 20252025-12-31Q3 20252025-09-30Q2 20252025-06-30Q1 20252025-03-31Q4 20242024-12-31Q3 20242024-09-30Q2 20242024-06-30Q1 20242024-03-31Q2 20192019-06-30
Revenue19.96M21.48M12.64M12.48M13.65M12.85M7.90M10.31M12.32M12.89M9.36M0
Revenue growth (YoY)+46.15%+67.13%+59.97%+20.97%+10.85%-0.26%-15.60%————-100.00%
Cost of Revenue14.22M15.48M9.67M9.39M10.40M9.72M6.57M8.24M9.32M10.12M7.61M—
Gross Profit5.74M6.00M2.97M3.08M3.25M3.13M1.32M2.07M2.99M2.76M1.75M—
Operating Expenses5.33M5.57M4.47M11.61M4.02M3.39M2.75M2.42M2.58M2.75M2.46M605.00K
Research & Development———————————339.00K
Selling, General & Admin5.24M5.51M4.47M4.86M3.37M3.39M2.75M2.42M2.58M2.75M2.46M—
Operating Income406.00K432.00K-1.50M-8.53M-768.00K-260.00K-1.43M-348.00K413.00K14.00K-717.00K-605.00K
Interest Expense1.07M1.96M892.00K2.55M594.00K440.00K300.00K335.00K374.00K394.00K380.00K—
Other Income (Expense)000—000—00—-63.00K
Pretax Income-631.00K-1.38M-1.91M-9.61M-2.01M-700.00K-1.73M-683.00K39.00K-380.00K-1.10M-668.00K
Income Tax1.00K3.00K2.00K7.18M000420.00K5.00K1.00K16.00K0
Net Income-632.00K-1.38M-1.92M-16.79M-2.01M-700.00K-1.73M-1.10M34.00K-381.00K-1.11M-668.00K
Net Income growth (YoY)————-6023.53%————-199.74%—-152.27%
EPS (Basic)-1.28-0.11-0.217.92-10.35-0.13-1.56-7.20-6.33-8.43-12.91-0.01
EPS (Diluted)————-0.35-0.13-0.47-7.20-6.33-8.43-12.91-0.01
Shares Outstanding (Basic)493.89K12.64M9.33M—194.60K5.24M1.56M—157.61K157.61K157.61K54.38K
Shares Outstanding (Diluted)————5.70M5.41M5.19M—157.61K157.61K157.61K54.38K
EBITDA548.00K595.00K-1.34M-8.49M-650.00K-146.00K-1.31M-404.00K538.00K135.00K-597.00K—
Gross Margin28.75%27.93%23.50%24.70%23.83%24.35%16.77%20.06%24.30%21.45%18.65%—
Operating Margin2.03%2.01%-11.85%-68.37%-5.62%-2.02%-18.08%-3.37%3.35%11.00%-7.66%—
Net Margin-3.17%-6.42%-15.16%-134.56%-14.75%-5.45%-21.88%-10.70%28.00%-2.96%-11.89%—

This table shows 12 quarterly periods of Capstone's income statement, from Q3 2026 back to Q2 2019, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow CAPS's reporting calendar. What is a income statement?

More financial data